Skip to content
Screener

Income Tax at other companies

Pfizer logo
PfizerPFE
-$407M-389%
Cardinal Health logo
Cardinal HealthCAH
$12M-92.4%
McKesson logo
McKessonMCK
$276M+25.5%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$12.39M+527%
Cencora logo
CencoraCOR
$219.73M+6.4%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$6.1M+134%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.77B+129%
Enterprise value$8.21B+77.4%
P/E36.7×-711×
P/S1.9×+1.0×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001723128-26-000031
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income, net6531,6041,3952,122
Total other expense, net(58,779)(59,661)(120,375)(122,522)
Income before income taxes70,99051,711151,16689,197
Provision for income taxes1,37616,1013,55228,969
Net income69,61435,610147,61460,228
Less: Net income attributable to non-controlling interests(11,952)(13,193)(27,696)(25,616)
Net income attributable to Amneal Pharmaceuticals, Inc.$57,662$22,417$119,918$34,612
Net income per share attributable to Amneal Pharmaceuticals, Inc.’s Class A common stockholders:

Item 1. Financial Statements (Unaudited)

FAQ

What is Amneal Pharmaceuticals, Inc.'s income tax?
Amneal Pharmaceuticals, Inc. (AMRX) reported income tax of $1.38M in Q2 2026.
How has Amneal Pharmaceuticals, Inc.'s income tax changed year-over-year?
Amneal Pharmaceuticals, Inc.'s income tax decreased by 91.5% year-over-year, from $16.1M to $1.38M.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s income tax?
Over 3 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s income tax has grown at a 0.2% compound annual growth rate (CAGR), from $11.2M to $11.28M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Ask your AI about Amneal Pharmaceuticals, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude